Group One Trading
NVLN

Group One Trading’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Group One Trading’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100,000
Closed -$73K – 5983
2019
Q3 		$73K Hold
100,000
– – ﹤0.01% 3774
2019
Q2 		$78K Buy
+100,000
New +$111K ﹤0.01% 3537
2018
Q3 		– Sell
-30,000
Closed -$110K – 5886
2018
Q2 		$110K Hold
30,000
– – ﹤0.01% 3508
2018
Q1 		$105K Buy
+30,000
New +$127K ﹤0.01% 3216
2017
Q2 		– Sell
-18,900
Closed -$203K – 5326
2017
Q1 		$203K Sell
18,900
-11,800
-38% -$121K ﹤0.01% 2511
2016
Q4 		$258K Buy
+30,700
New +$272K ﹤0.01% 2248

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Group One Trading's NVLN Position: Q4 2019 in Review

Group One Trading sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 52,068 shares — an estimated $38K sold.

Group One Trading first reported a position in NVLN in Q4 2016 and held it in 10 quarters. The position peaked at $106K in Q1 2017. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Group One Trading reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Group One Trading sold 52,068 Novelion Therapeutics Inc. Common Shares shares in Q4 2019, an estimated $38K.
  • Group One Trading first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 10 quarters.
  • Group One Trading's Novelion Therapeutics Inc. Common Shares position peaked at $106K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Group One Trading's 13F filing for Q4 2019, filed 10 Feb 2020.